US Patent Issued to Anavex Life Sciences on Jan. 27 for "Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof" (New York Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,352, issued on Jan. 27, was assigned to Anavex Life Sciences Corp. (New York).

"Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof" was invented by Christopher U. Missling (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for the treatment and/or prevention of pain which comprises administering to a subject in need of such treatment a therapeutically effective amount of 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and pharmaceutically acceptable salts thereof ("AV1066"), with reference to visceral and neuropathic pain."

The pa...